You are here

Home

Clinical Trials: Cord Blood

Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: a Placebo-controlled Randomized Multicenter Trial
Condition:   BPD
Interventions:   Biological: autologous cord blood mononuclear cells;   Biological: normal saline
Sponsors:   Guangdong Women and Children Hospital;   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   Third Affiliated Hospital, Sun Yat-Sen University;   Nanfang Hospital of Southern Medical University;   Zhongshan Boai Hospital;   Foshan Chancheng Central Hospital;   Foshan Women and Children Hospital;   Guangdong Second Provincial General Hospital;   Hexian Memorial Affiliated Hospital of Southern Medical University;   Heyuan Women and Children Hospital;   Jiangmen Women and Children Hospital;   Dongguan Women and Children Hospital;   Guangzhou Huadu Women and Children Hospital;   The fifth Affiliated Hospital of Guangzhou Medcial University;   Guang Dong Cord Blood and Stem Cell Bank, Guangzhou , China
Not yet recruiting
Using Cord Blood in Treatment of Covid -19
Condition:   Virus
Intervention:   Combination Product: stem cells
Sponsor:   Aljazeera Hospital
Not yet recruiting
Follow-up Safety and Explore Efficacy Evaluation on Subjects Who Completed SMUP-IA-01 Phase I Clinical Trial
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low-dose);   Biological: SMUP-IA-01(mid-dose);   Biological: SMUP-IA-01(high-dose)
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury
Condition:   Spinal Cord Contusion
Intervention:   Biological: Human Allogeneic Umbilical Cord Blood Mononuclear Cells (hUCBMCs) systemic (i.v.) infusions
Sponsors:   Sklifosovsky Institute of Emergency Care;   National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Completed
Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
Condition:   Chondral or Osteochondral Lesion of Talus
Interventions:   Biological: CARTISTEM®;   Procedure: Microfracture
Sponsors:   SK bioland co., ltd.;   Medipost Co Ltd.
Enrolling by invitation
Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Condition:   Severe Acute Respiratory Syndrome (SARS) Pneumonia
Intervention:   Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Hackensack Meridian Health
Not yet recruiting
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
Condition:   Hematological Malignancies
Intervention:   Biological: omidubicel
Sponsor:   Gamida Cell ltd
Not yet recruiting
Treatment of Osteoarthritic Knee With High Tibial Osteotomy and Implantation of Allogenic Human Umbilical Cord Blood-derived Stem Cells.
Condition:   Osteoarthritis, Knee
Intervention:   Procedure: umbilical cord blood stem cell implantation for osteoarthritis treatment
Sponsor:   Uijeongbu St. Mary Hospital
Not yet recruiting
Efficacy and Safety of hUC-MSCs and hUCB-MSCs in the Treatment of Chronic Spinal Cord Injury
Condition:   Spinal Cord Injuries
Intervention:   Other: Stem cell transplantation
Sponsor:   The First Affiliated Hospital of Dalian Medical University
Recruiting
Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation
Condition:   Haematologic Disease
Intervention:   Combination Product: CTL 19
Sponsors:   Nantes University Hospital;   INSERM U01232 CRCINA
Not yet recruiting

Pages